Skip to main content

BLRX · BioLineRx Ltd. · Short Volume

Track BLRX — free
$2.21 +0.23 (+11.84%) At close · Oct 20
Market Cap
$11.02M
Shares
4.98M
Volume · Oct 20 3057 Avg daily vol (3M) 17.32K

Daily short-sale volume published by FINRA from its trade-reporting facilities. It measures how many shares were sold short each day as a share of total volume — a daily flow, not the total outstanding short position.

Short Volume

Date Short Volume Short Exempt Total Volume Short %
2026-10-20 1,253 0 2,727 45.9%
2026-10-19 2,253 100 4,947 45.5%
2026-10-16 1,961 0 4,432 44.2%
2026-10-15 2,616 0 13,043 20.1%
2026-10-14 915 0 3,425 26.7%
2026-10-13 2,850 3 5,776 49.3%
2026-10-12 5,379 0 11,204 48.0%
2026-10-09 488 0 3,622 13.5%
2026-10-08 1,727 0 5,079 34.0%
2026-10-07 434 0 4,508 9.6%
2026-10-06 4,470 37 15,458 28.9%
2026-10-05 187 0 4,970 3.8%
2026-10-02 402 0 1,938 20.7%
2026-10-01 465 0 2,565 18.1%
2026-09-30 1,030 0 10,674 9.7%
2026-09-29 636 0 2,479 25.7%
2026-09-28 1,655 0 8,603 19.2%
2026-09-25 1,914 0 4,270 44.8%
2026-09-24 3,849 0 8,353 46.1%
2026-09-23 1,797 0 8,030 22.4%
2026-09-22 447 0 3,699 12.1%
2026-09-21 359 0 2,794 12.9%
2026-09-18 212 0 1,451 14.6%
2026-09-17 1,378 982 6,317 21.8%
2026-09-16 680 0 2,510 27.1%
2026-09-15 947 0 1,634 58.0%
2026-09-14 669 0 1,810 37.0%
2026-09-11 125 0 2,916 4.3%
2026-09-10 2,413 0 4,476 53.9%
2026-09-09 318 0 969 32.8%
2026-09-08 1,716 0 3,601 47.6%
2026-09-04 918 0 2,959 31.0%
2026-09-03 2,374 0 8,533 27.8%
2026-09-02 618 0 8,969 6.9%
2026-09-01 4,486 0 37,402 12.0%
2026-08-31 11,306 0 42,021 26.9%
2026-08-28 5,485 0 11,130 49.3%
2026-08-27 208 0 644 32.3%
2026-08-26 1,070 0 5,149 20.8%
2026-08-25 680 0 4,398 15.5%
2026-08-24 1,008 0 3,209 31.4%
2026-08-21 501 0 1,914 26.2%
2026-08-20 215 0 986 21.8%
2026-08-19 113 0 1,514 7.5%
2026-08-18 387 0 7,467 5.2%
2026-08-17 882 0 3,807 23.2%
2026-08-14 866 0 1,406 61.6%
2026-08-13 314 0 3,310 9.5%
2026-08-12 461 0 3,088 14.9%
2026-08-11 66 0 3,304 2.0%
Showing 1–50 of 65 days
Key facts CIK 1498403 CUSIP 09071M304 Visit website Investor relations